Pembrolizumab
Merck
['pembro', 'key,note,789', 'key,note,45', 'sclc', 'nsclc']
#asco23 abs#9000
pem + platinum +/- pembro for tyrosine kinase inhibitor (tki)-resistant, egfr-mutant, metastatic nonsquamous nsclc: phase 3 keynote-789 study
practice affirming or practice changing?
#lscm oral session!
tue, 6/6 d1 945cdt 
Leslye M. Heisler Associate Professor of Lung Cancer Excellence @PennMedicine | AD @PC31 | Incoming Chair @ASCO #CCC | Tweets my own | COI: https://t.co/ghKU8KhBvl